PWODWI APLIKASYON
Nou toujou ap devlope nouvo pwodwi pou ankouraje devlopman dirab.
Konsènan konpayi
Nou toujou ap devlope nouvo pwodwi pou ankouraje devlopman dirab.
Konpayi Profile
Shijiazhuang Kunxiangda teknoloji co, Ltd.
te etabli nan 2011. nou se yon fabrike pwofesyonèl pou pharmaceutique entèmedyè ak konpayi komès pou koloran entèmedyè, ak lòt matyè premyè chimik. Faktori nou an sitiye nan zòn devlopman ekonomik ak teknolojik nan vil Shijiazhuang, pwovens Hebei. Zòn total yo se apeprè 50 kawo tè, e gen plis pase 300 anplwaye, ki gen ladan 9 anplwaye teknik.
0
Ane Eksperyans
0
Peyi ekspòtasyon
0
Anplwaye aktyèl la
Mache Global nou an
Pwodwi yo ekspòte nan Ewòp, Amerik di Sid, Azi, Mwayen Oryan ak lòt plizyè douzèn peyi ak rejyon yo, epi tou li etabli yon rezo maketing ki gen matirite ak ki estab.
6Kontinan
35Peyi oswa rejyon yo
Li Dènye Nouvèl Nou yo
Nou toujou ap devlope nouvo pwodwi pou ankouraje devlopman dirab.
Aug.08,2025
Synthesis of Heterocyclic Compounds Using 1,3-Dimethylurea: Expanding Horizons in Pharmaceutical Intermediates Production
The pharmaceutical industry continues to discover innovative applications for 1,3-dimethylurea as a versatile building block in heterocyclic compound synthesis.
Li Plis NouvèlAug.08,2025
Sevoflurane Mechanism of Action in the Brain: Unraveling the Molecular Pathways
Sevoflurane, a fluorinated methyl isopropyl ether, has become one of the most widely used inhalation anesthetics in modern medical practice, with its active pharmaceutical ingredient specifically designed to target neural circuits.
Li Plis Nouvèl